Good afternoon :)
Place Order
Add to Watchlist

Krebs Biochemicals and Industries Ltd

KREBSBIO

Krebs Biochemicals and Industries Ltd

KREBSBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹170 cr, stock is ranked 2,593
High RiskStock is 3.97x as volatile as Nifty
79.300.32% (+0.25)
79.300.32% (+0.25)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹170 cr, stock is ranked 2,593
High RiskStock is 3.97x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹170 cr, stock is ranked 2,593
High RiskStock is 3.97x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-8.7015.81
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.226.550.48%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 1.08%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.02% to 0.01%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue3.883.6534.1348.2033.7854.3260.8652.7550.8753.17
Raw Materialssubtract1.771.3417.1220.9919.1825.6246.1819.815.5261.04
Power & Fuel Costsubtract2.870.708.6211.7010.2815.9122.2314.8022.01
Employee Costsubtract5.675.6311.4914.4114.5615.3014.9615.5416.17
Selling & Administrative Expensessubtract3.132.523.433.834.013.396.114.574.50
Operating & Other expensessubtract1.521.781.986.593.9411.054.2213.2010.95
Depreciation/Amortizationsubtract4.494.234.154.404.685.126.306.566.776.80
Interest & Other Itemssubtract0.743.495.176.296.006.285.392.974.694.91
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
EPS-13.95-11.56-12.53-12.97-16.67-15.07-21.63-11.46-9.16-9.08
DPS0.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Krebs Biochemicals and Industries Ltd-8.6315.81
Sun Pharmaceutical Industries Ltd47.866.830.71%
Cipla Ltd31.814.890.80%
Torrent Pharmaceuticals Ltd70.9717.150.81%

Price Comparison

Compare KREBSBIO with any stock or ETF
Compare KREBSBIO with any stock or ETF
KREBSBIO
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding72.74%0.00%0.00%0.50%26.76%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

KREBSBIO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024 as against net loss of Rs 5.33 crore during the previous quarter ended June 2023. Sales rose 21.83% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 10.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8910.58 22 OPM %-16.99-24.76 - PBDT-3.48-3.68 5 PBT-5.17-5.33 3 NP-5.17-5.33 3 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Krebs Biochemicals & Industries to announce Quarterly Result

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live

Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group

2 months agoBusiness Standard
Spotlight
Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

North Eastern Carrying Corporation Ltd, Capital Trust Ltd, Kilitch Drugs (India) Ltd and Gujarat Raffia Industries Ltd are among the other gainers in the BSE's 'B' group today, 19 July 2024.Krebs Biochemicals & Industries Ltd soared 16.09% to Rs 118.84 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 14701 shares in the past one month. North Eastern Carrying Corporation Ltd spiked 15.10% to Rs 36.06. The stock was the second biggest gainer in 'B' group. On the BSE, 4.15 lakh shares were traded on the counter so far as against the average daily volumes of 1.53 lakh shares in the past one month. Capital Trust Ltd surged 14.60% to Rs 136.95. The stock was the third biggest gainer in 'B' group. On the BSE, 85581 shares were traded on the counter so far as against the average daily volumes of 5237 shares in the past one month. Kilitch Drugs (India) Ltd exploded 10.00% to Rs 361.95. The stock was the fourth biggest gainer in 'B' group. On the BSE, 15931 shares were traded on the counter so far as against the average daily volumes of 1726 shares in the past one month. Gujarat Raffia Industries Ltd gained 9.99% to Rs 53.38. The stock was the fifth biggest gainer in 'B' group. On the BSE, 5819 shares were traded on the counter so far as against the average daily volumes of 5167 shares in the past one month. Powered by Capital Market - Live

2 months agoCapital Market - Live

Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group

2 months agoBusiness Standard
Spotlight
Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Remedium Lifecare Ltd, Mahanagar Telephone Nigam Ltd, Coastal Corporation Ltd and Quick Heal Technologies Ltd are among the other gainers in the BSE's 'B' group today, 18 July 2024.Krebs Biochemicals & Industries Ltd spiked 20.00% to Rs 102.37 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.36 lakh shares were traded on the counter so far as against the average daily volumes of 7515 shares in the past one month. Remedium Lifecare Ltd surged 18.73% to Rs 19.02. The stock was the second biggest gainer in 'B' group. On the BSE, 48.35 lakh shares were traded on the counter so far as against the average daily volumes of 25.82 lakh shares in the past one month. Mahanagar Telephone Nigam Ltd soared 18.48% to Rs 63.21. The stock was the third biggest gainer in 'B' group. On the BSE, 72.37 lakh shares were traded on the counter so far as against the average daily volumes of 15.74 lakh shares in the past one month. Coastal Corporation Ltd gained 14.43% to Rs 282.7. The stock was the fourth biggest gainer in 'B' group. On the BSE, 90635 shares were traded on the counter so far as against the average daily volumes of 9778 shares in the past one month. Quick Heal Technologies Ltd exploded 12.96% to Rs 615.3. The stock was the fifth biggest gainer in 'B' group. On the BSE, 84325 shares were traded on the counter so far as against the average daily volumes of 14223 shares in the past one month. Powered by Capital Market - Live

2 months agoCapital Market - Live

Shashijit Infraprojects Ltd leads losers in ‘B’ group

3 months agoBusiness Standard

Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group

3 months agoBusiness Standard

Vesuvius India Ltd leads losers in ‘B’ group

1 year agoBusiness Standard